Because of how clinical trials need to be done – for safety reasons and for scientific reasons – doctors need to set up criteria for which patients can participate in the study.
A clinical trial is essentially an experiment with willing participants, and doctors need to be able to interpret the data they receive from these trials. This can be very frustrating for patients. But the logic behind the exclusion criteria is that if a patient has extremely advanced cancer and may not make it until the end of the trial, the data could be compromised.
Clinical trials are extremely important when it comes to cancer research – and they can improve the odds for people facing advanced diseases. But there are some restrictions for these studies.
Overview of Treatment for Advanced Breast Cancer
Stage Four Breast Cancer
When Breast Cancer Spreads to the Bones
Metastatic Breast Cancer: You Are Not a Statistic
What Are CD4/CD6 Inhibitors? And How Can They Fight Advanced Breast Cancer?
Treating Metastatic Hormone Receptor-Positive Breast Cancer
Hormone Therapies for Breast Cancer: CDK 4/6 Inhibitors
CDK4/6 Inhibitors for Breast Cancer Explained
CD4/CD6 Inhibitors For Metastatic Breast Cancer -- What Are The Side Effects?
Hormone Therapies for Breast Cancer: mTOR Inhibitors
The FDA Just Approved a Promising New Drug for Metastatic Breast Cancer
New Breast Cancer Drug Combination Shows Promising Results
Breast Cancer Breakthrough: Immunotherapy Shows Major Boost in Survival Rates
Chemo Plus Immunotherapy for Metastatic Triple-Negative Breast Cancer
New Drug Extends Life in Most Aggressive Breast Cancer
What's Next for Breast Cancer and Immunotherapy?
Immunotherapy and Triple Negative Breast Cancer
PARP Inhibitors Provide New Promise for Certain Metastatic Breast Cancers